https://www.marketscreener.com/quote/stock/EVEREST-MEDICINES-LIMITED-119080123/news/Everest-Medicines-Announces-China-NMPA-Has-Granted-Priority-Review-for-Sacituzumab-Govitecan-hziy-in-33380801/?utm_source=telegram&utm_medium=social&utm_campaign=share